Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MPSK3169A in patients with coronary heart disease or high risk of coronary heart disease
2012-000191-41Phase 2Completed
- Sponsor
- Genentech
- Start
- May 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RG-7652 in coronary arteriosclerosis, hypercholesterolemia, sponsored by Genentech. Started May 2012; status: completed.
02
Drugs
RG-7652
03
Conditions
coronary arteriosclerosishypercholesterolemia
Beyond the preview
Go deeper on 2012-000191-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000191-41.